Zhe-qi Xu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Cost-effectiveness analysis of anlotinib plus penpulimab as first-line treatment for unresectable hepatocellular carcinoma.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: August 17, 2026
α7 Nicotinic Acetylcholine Receptor as a Therapeutic Target in Central Nervous System Diseases: Prospects and Limitations.
Journal: Current neuropharmacology
Published: May 20, 2025
Cellular responses and functions of α7 nicotinic acetylcholine receptor activation in the brain: a narrative review.
Journal: Annals of translational medicine
Published: April 14, 2021
Autophagy is Involved in Neuroprotective Effect of Alpha7 Nicotinic Acetylcholine Receptor on Ischemic Stroke.
Journal: Frontiers in pharmacology
Published: March 05, 2021
Activating α7 nicotinic acetylcholine receptor inhibits NLRP3 inflammasome through regulation of β-arrestin-1.
Journal: CNS neuroscience & therapeutics
Published: July 09, 2017
Intestinal Autophagy and Its Pharmacological Control in Inflammatory Bowel Disease.
Journal: Frontiers in immunology
Published: November 19, 2016
Combined administration of anisodamine and neostigmine rescued acute lethal crush syndrome through α7nAChR-dependent JAK2-STAT3 signaling.
Journal: Scientific reports
Published: July 06, 2016
Treatment for Ischemic Stroke: A New Approach from the Ancient Art of War.
Journal: CNS neuroscience & therapeutics
Published: January 16, 2016
NLRP3 inflammasome and its inhibitors: a review.
Journal: Frontiers in pharmacology
Published: September 05, 2015
Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome.
Journal: CNS neuroscience & therapeutics
Published: September 24, 2014
Last Updated: 09/26/2026